Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F1KP
|
||||
Former ID |
DCL001226
|
||||
Drug Name |
PSN821
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Terminated | [550284] | ||
Company |
Astellas Pharma Inc
|
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [550284] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.